AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NOVO RESOURCES CORP-CDI

0.100

-0.010-9.09%

Volume:30.43K

Turnover:3.17K

Market Cap:35.46M

PE:-1.35

High:0.105

Open:0.105

Low:0.100

Close:0.110

Loading ...

Overview Company News Filings

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Gains 2% for Week

MT Newswires Live

Novo Nordisk Stock Jumps on Early Stage Weight-Loss Drug Trial Results

Sector Update: Health Care Stocks Decline Premarket Friday

MT Newswires Live

S&P 500 Gains and Losses Today: Intel Stock Soars as Takeover Speculation Spreads

Sector Update: Health Care Stocks Softer Friday Afternoon

MT Newswires Live

Top Midday Stories: Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks; Supreme Court Allows TikTok Ban to Take Effect

MT Newswires Live

European Equities Traded in the US as American Depositary Receipts Edge Higher Friday

MT Newswires Live

Novo Nordisk Says Trial of Higher Dose Semaglutide Achieved Primary Endpoint

MT Newswires Live

Market Chatter: Novo Nordisk Controlling Shareholder Looks to Double Catalent's Size Over Five Years

MT Newswires Live

Diageo's Challenges Posed by GLP-1 Weight-Loss Drugs Cited by Fundsmith Manager for Selling Stake

MT Newswires Live

European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading

MT Newswires Live

Novo Nordisk, Valo Health Expand Collaboration to Include Obesity, Diabetes Programs

MT Newswires Live

European Equities Traded in US as American Depositary Receipts Surge on Monday

MT Newswires Live

Novo Resources Starts Trading on OTCQB

MT Newswires Live

Novo Resources to Trade on the OTCQB Market

Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea

European Equities Traded in the US as American Depositary Receipts Start Week Down Slightly in Monday Trading

MT Newswires Live

Equity Markets Rise as Traders Evaluate Macro Data

MT Newswires Live

US Equities Markets End Higher Friday as Investors Evaluate Macro Data

MT Newswires Live

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NVO.AU/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVO.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVO.AU\",,,,,undefined,":{"symbol":"NVO.AU","market":"AU","secType":"STK","nameCN":"NOVO RESOURCES CORP-CDI","latestPrice":0.1,"timestamp":1745388720000,"preClose":0.11,"halted":0,"volume":30426,"delay":0,"nameEN":"NOVO RESOURCES CORP-CDI","floatShares":314709406,"shares":354630279,"eps":-0.07422100553182331,"marketStatus":"Not Yet Opened","change":-0.01,"latestTime":"04-23 16:12:00 AEST","open":0.105,"high":0.105,"low":0.1,"amount":3172,"amplitude":0.045455,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.07422100553182331,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745452800000},"marketStatusCode":0,"adr":0,"adrRate":1,"listingDate":1694268000000,"exchange":"ASX","adjPreClose":0.11,"openAndCloseTimeList":[[1745366400000,1745388000000]],"volumeRatio":0.2856048613252326,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVO.AU\",,,,,undefined,":{"symbol":"NVO.AU","floatShares":314709406,"roa":"-13.14%","roe":"-30.09%","lyrEps":-0.074221,"volumeRatio":0.2856048613252326,"shares":354630279,"dividePrice":0,"high":0.105,"amplitude":0.045455,"preClose":0.11,"low":0.1,"week52Low":0.081,"pbRate":"0.45","psRate":"12.55","week52High":0.165,"institutionHeld":0,"latestPrice":0.1,"eps":-0.07422100553182331,"divideRate":0,"volume":30426,"delay":0,"ttmEps":-0.07422100553182331,"open":0.105,"prevYearClose":0.094,"prevWeekClose":0.1,"prevMonthClose":0.098,"prevQuarterClose":0.098,"fiveDayClose":0.11,"twentyDayClose":0.097,"sixtyDayClose":0.094},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVO.AU\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2506700867","title":"European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Gains 2% for Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2506700867","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506700867?lang=en_us&edition=fundamental","pubTime":"2025-01-25 00:13","pubTimestamp":1737735218,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking higher late Friday morning, gaining 0.53% to 1,358.93 on the S&P Europe Select ADR Index, and raising the week's return","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4515","LU0300736062.USD","EVAX","BK4599","BK4546","BK4023","LU0154236417.USD","SQNS","BK4169","NVO.AU","BK4588","LU1093756168.USD","BK4007","87807D608","BK7104","ERIC","AUTL","BK4077","BK4141","NVO","LU0098860793.USD","BK4505","IE00BZ1G4Q59.USD","BK4591","IE00BKVL7J92.USD","IE00BMPRXN33.USD","IE00BMPRXR70.SGD","IHG","LU0300736492.USD","MTLS","BK4139","DGE.UK","LU0320765646.SGD","BK4020","BK4585","DEO","GRFS","BK4201","BK4554","AFG","NOK","BK4142","AKTX","SHEL","MREO","TCBP","AMRN","TRVG","LU1093756325.SGD","BK4532","BK4117"],"gpt_icon":1},{"id":"2505629258","title":"Novo Nordisk Stock Jumps on Early Stage Weight-Loss Drug Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2505629258","media":"Investopedia","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505629258?lang=en_us&edition=fundamental","pubTime":"2025-01-24 22:41","pubTimestamp":1737729669,"startTime":"0","endTime":"0","summary":"Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for its amycretin weight-loss drug.The maker of Ozempic and Wegovy said that its Phase 1b/2a trial showed people achieved weight loss from a mean baseline body weight of 92.7 kg  in three different maintenance doses, while those treated with placebo gained weight.Novo Nordisk shares have been trending lower since September on slowing sales and increasing competition in the weight-loss drug market.Novo Nordisk's  U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for its amycretin weight-loss drug.The maker of Ozempic and Wegovy said that its Phase 1b/2aclinical trial showed people achieved weight loss from a mean baseline body weight of 92.7 kg  in three different maintenance doses, while those treated with placebo gained weight. In the highest dosage, 20mg, participants lost 22% of body weight after 36 weeks, whil","market":"fut","thumbnail":"https://www.investopedia.com/thmb/FJTPFL2uR0SaFpZiHrxF5DFzMNw=/5615x3743/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2186511013-35d19a76166947a8a692d8009b279682.jpg","type":0,"news_type":0,"thumbnails":["https://www.investopedia.com/thmb/FJTPFL2uR0SaFpZiHrxF5DFzMNw=/5615x3743/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2186511013-35d19a76166947a8a692d8009b279682.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investopedia.com/novo-nordisk-stock-jumps-on-early-stage-weight-loss-drug-trial-results-8779639","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"investopedia_highlight","symbols":["LU1548497426.USD","LU0079474960.USD","NVO.AU","LU2264538146.SGD","LU2468319806.SGD","SSI","LU1127390331.HKD","IE0009355771.USD","LU0203202063.USD","BK4532","LU1023059063.AUD","LU1983299246.USD","SG9999014906.USD","LU1720051017.SGD","LU1093756168.USD","SG9999018865.SGD","SG9999001176.USD","LU2491049909.HKD","LU0198837287.USD","LU0238689110.USD","LU0061475181.USD","LU2602419157.SGD","LU1868837136.USD","NVO","LU1069344957.HKD","LU1093756325.SGD","BK4007","LU0640476718.USD","LU2237443895.HKD","LU2361045086.USD","LU0689472784.USD","BK4516","LU2237443382.USD","LU0114720955.EUR","LU0820561909.HKD","LU0708995401.HKD","IE00BK4W5L77.USD","LU1868836591.USD","LU2237438978.USD","LU2237443465.HKD","LU2237443549.SGD","LU2237443622.USD","GB00BDT5M118.USD","LLY","LU0823416689.USD","LU1623119135.USD","BK4585","LU2106854487.HKD","LU0820561818.USD","LU0096364046.USD"],"gpt_icon":1},{"id":"2505788865","title":"Sector Update: Health Care Stocks Decline Premarket Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2505788865","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505788865?lang=en_us&edition=fundamental","pubTime":"2025-01-24 22:26","pubTimestamp":1737728817,"startTime":"0","endTime":"0","summary":"Health care stocks were declining premarket Friday as the Health Care Select Sector SPDR Fund (XLV) was down 0.4% and the iShares Biotechnology ETF (IBB) was 0.2% lower recently.Novo Nordisk (NVO) sha","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4548","IE00BZ1G4Q59.USD","BK4599","XLV","BK4139","BK4501","BK7104","BK4581","NVO.AU","BK4568","IBB","ALUR","BK4551","BK4585","LU1093756325.SGD","BK4192","LU0154236417.USD","NVO","BK4007","IE00BKVL7J92.USD","LU1093756168.USD","BK4588","BK4534","MRNA","BK4532","BK4533"],"gpt_icon":1},{"id":"2504143671","title":"S&P 500 Gains and Losses Today: Intel Stock Soars as Takeover Speculation Spreads","url":"https://stock-news.laohu8.com/highlight/detail?id=2504143671","media":"Investopedia","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504143671?lang=en_us&edition=fundamental","pubTime":"2025-01-18 06:03","pubTimestamp":1737151416,"startTime":"0","endTime":"0","summary":"The S&P 500 jumped 1% on Friday, Jan. 17, 2025, heading into a three-day weekend on a high note as prospects rebounded for additional interest-rate cuts in 2025.Intel shares took off following reports that the semiconductor giant could be an acquisition target.Freight shipper J.B. Hunt posted lower-than-expected sales and profits for the fourth quarter, and its shares dropped.Major U.S. equities indexes pushed higher to end the week, with traders set for a day off in observation of Martin Luther King Jr. Day on a Monday that will also see the swearing-in of Donald Trump for his second presidential term.The strength among stocks to close out the week coincided with rejuvenated optimism that the Federal Reserve could continue to lower interest rates in 2025, bolstered by indications of ebbing inflation. . The S&P 500 advanced 1% on Friday. Strength in the tech sector helped lift the Nasdaq 1.5%, while the Dow ended the day 0.8% higher.Eli Lilly  shares fell 4.2%, extending losses posted ","market":"fut","thumbnail":"https://www.investopedia.com/thmb/_m8hdbd-Bwhk9bdJ2TenEuGkzt8=/3744x2496/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2164837685-2cf129b9dc96463db2dba7c15b9f31a4.jpg","type":0,"news_type":0,"thumbnails":["https://www.investopedia.com/thmb/_m8hdbd-Bwhk9bdJ2TenEuGkzt8=/3744x2496/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2164837685-2cf129b9dc96463db2dba7c15b9f31a4.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investopedia.com/sandp-500-gains-and-losses-today-intel-soars-as-takeover-speculation-spreads-8776716","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investopedia_highlight","symbols":["LU2361044865.SGD","LU0985489474.SGD","LU1280957306.USD","NVO.AU","LU0353189763.USD","IE00BFTCPJ56.SGD","BK4579","LU0203202063.USD","LU1057294990.SGD","SDS","UPRO","LU0077335932.USD","LU0256863811.USD","SLB","SSO","SPY","IE0002270589.USD","JBHT","LU1983299246.USD","OEF","SLB.AU","SG9999018865.SGD","LU0300736062.USD","LU1489326972.SGD","BK4533","FICO","LU0882574139.USD","NVO","SGXZ31699556.SGD","LU0368265418.SGD","VOO",".SPX","INTC","BK4516","ESmain","LU1804176565.USD","SPXU","SGXZ23171101.USD","LU1061106388.HKD","LU0708995401.HKD","TFC","IE00BZ1G4Q59.USD","OEX","LLY","LU1720051108.HKD","SGXZ57979304.SGD","IVV","SH","LU0820561818.USD","LU0096364046.USD"],"gpt_icon":1},{"id":"2504435118","title":"Sector Update: Health Care Stocks Softer Friday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2504435118","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504435118?lang=en_us&edition=fundamental","pubTime":"2025-01-18 03:00","pubTimestamp":1737140457,"startTime":"0","endTime":"0","summary":"Health care stocks declined Friday afternoon with the NYSE Health Care Index down 0.6% and the Health Care Select Sector SPDR Fund (XLV) easing 0.1%.The iShares Biotechnology ETF (IBB) rose 0.3%.In co","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVO.AU","BK4599","NVO","BK4532","BK4581","ZTEK","IE00BKVL7J92.USD","BK4585","ZLAB","BK4139","BK4548","BK7104","LU1093756168.USD","BK4526","LU0154236417.USD","BK4198","IE00BZ1G4Q59.USD","BK4007","LU1093756325.SGD","XLV","BK4531","IBB","BK4588"],"gpt_icon":1},{"id":"2504191119","title":"Top Midday Stories: Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks; Supreme Court Allows TikTok Ban to Take Effect","url":"https://stock-news.laohu8.com/highlight/detail?id=2504191119","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504191119?lang=en_us&edition=fundamental","pubTime":"2025-01-18 01:14","pubTimestamp":1737134043,"startTime":"0","endTime":"0","summary":"Wall Street's major market averages were higher around midday Friday ahead of a long Martin Luther King, Jr. holiday weekend and the inauguration of President-elect Donald Trump.In company news, Novo ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SLB","UDOW","SDOW","BK4211","PSQ","NVO","LU0154236417.USD","BK4532","DXD","LU0208291251.USD","JBHT","LU2357305700.SGD","USAW.SI","QID","TFC","SG9999004303.SGD","LU1489326972.SGD","LU0320765489.SGD","BK4179","IE00BZ1G4Q59.USD","DOG","LU0878866978.SGD","LU2237438978.USD","TQQQ","FAST","SLB.AU","TSYW.SI","DDM","IE00BFXG0V08.USD","BK4599","LU0256331488.USD",".SPX","LU0211331839.USD","DJX",".DJI","BK4007","BK4588","NVIW.SI","NVO.AU","LU1548497426.USD","SQQQ","MNQmain","IE00B19Z3B42.SGD",".IXIC","QLD","NQmain","USJW.SI","LU0077335932.USD","BK4022"],"gpt_icon":1},{"id":"2504619548","title":"European Equities Traded in the US as American Depositary Receipts Edge Higher Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2504619548","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504619548?lang=en_us&edition=fundamental","pubTime":"2025-01-18 00:20","pubTimestamp":1737130858,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were edging up on Friday morning, up 0.2% to 1,328.33 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by e-commerce company MYT  and cybersecurity company WiseKey , which rose 10% and nearly 5% respectively.They were followed by semiconductor company STMicroelectronics , which was adding 2.4%.The decliners from continental Europe were led by pharmaceutical company Novo Nordisk  and biotech company Evaxion , which fell 4.3% and 3.3% respectively.From the UK and Ireland, the gainers were led by insurance provider Prudential  and cruise operator Carnival , which rose 4.2% and 3.6% respectively.The decliners from the UK and Ireland were led by cell therapy company TC Biopharm  and medical products maker Trinity Biotech , which dropped 6.1% and 3.1% respectively.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4162","BK4554","LU0154236417.USD","IE00BMPRXR70.SGD","IE00BMPRXN33.USD","TCBP","EVAX","BK4107","BK4139","BK7104","WKEY","BK4007","BK4588","IE00BZ1G4Q59.USD","BK4082","BK4142","BK7095","NVO","STM","AFG","BK4585","LU1093756325.SGD","LU1093756168.USD","IE00BKVL7J92.USD","TRIB","BK4117","CUK","BK4532","NVO.AU","PUK","BK4141","STM.AU","BK4094","MYTE","BK4599","BK4565"],"gpt_icon":1},{"id":"2504150099","title":"Novo Nordisk Says Trial of Higher Dose Semaglutide Achieved Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2504150099","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504150099?lang=en_us&edition=fundamental","pubTime":"2025-01-17 21:07","pubTimestamp":1737119231,"startTime":"0","endTime":"0","summary":"Novo Nordisk  said Friday its phase 3b trial comparing subcutaneous semaglutide 7.2 mg with semaglutide 2.4 mg and placebo achieved its primary endpoint by demonstrating a \"statistically significant and superior\" weight loss at week 72.The trial, which involved 1,407 adults with obesity, showed participants administered with semaglutide 7.2 mg on a weekly basis alongside lifestyle interventions achieved a 20.7% weight loss from a mean baseline weight of 113 kg. This compares to a 17.5% reduction with semaglutide 2.4 mg and 2.4% with placebo.The trial demonstrated that 33.2% of participants receiving semaglutide 7.2 mg achieved at least 25% weight loss, outperforming the 16.7% with semaglutide 2.4 mg and 0% with placebo.Novo Nordisk said the semaglutide 7.2 mg demonstrated a safe and well-tolerated profile, with most adverse events being mild to moderate gastrointestinal issues that diminished over time.Novo Nordisk shares were 2.5% lower in premarket trading.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0154236417.USD","NVO","LU1093756168.USD","BK7104","NVO.AU","BK4532","LU1093756325.SGD","BK4599","BK4585","BK4007","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4588"],"gpt_icon":1},{"id":"2504615204","title":"Market Chatter: Novo Nordisk Controlling Shareholder Looks to Double Catalent's Size Over Five Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2504615204","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504615204?lang=en_us&edition=fundamental","pubTime":"2025-01-17 20:41","pubTimestamp":1737117665,"startTime":"0","endTime":"0","summary":"Novo Nordisk's  controlling shareholder, Novo Holdings, is looking to double the size of Catalent over five years as President-elect Donald Trump is likely to focus on US manufacturing, Reuters reported, citing an interview with a Novo Holdings senior partner.Jonathan Levy said the company did not want to set a revenue target before agreeing on a corporate strategy with Catalent's management but noted that \"doubling the size of your business over five years is always a nice barometer to work on,\" according to the report.Levy said Catalent is set to hold its next board meeting in February, Reuters added.Novo Holdings and Catalent did not immediately respond to MT Newswires' requests for comments.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVO.AU","LU1093756168.USD","LU0154236417.USD","BK4532","BK7104","BK4585","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVO","CTLT","BK4599","BK4007","BK4530","IE00BKVL7J92.USD","BK4588"],"gpt_icon":1},{"id":"2502042303","title":"Diageo's Challenges Posed by GLP-1 Weight-Loss Drugs Cited by Fundsmith Manager for Selling Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2502042303","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502042303?lang=en_us&edition=fundamental","pubTime":"2025-01-10 01:02","pubTimestamp":1736442164,"startTime":"0","endTime":"0","summary":"Diageo  shares were on the chopping block for UK fund manager Terry Smith during 2024, with the veteran investor questioning whether the spirits and brewery company will be up to the potential challenge posed by GLP-1 weight-loss drugs on alcohol producers.In his annual message to Fundsmith clients, Smith this week cited growing signs GLP-1 drugs, including Novo Nordisk's  Wegovy and Ozempic, also work to suppress users desire for alcohol to explain why he sold his stake in the maker of Johnny Walker whisky and Guinness ale.\"We suspect the entire drinks sector is in the early stages of being impacted negatively by weight loss drugs,\" Smith wrote, later noting it appears likely GLP-1 medications will also be soon used to treat alcoholism. He also chided management at Diageo for \"a lack of information\" about collapsing demand for its brands in Latin America beginning in late 2023.Diageo did not immediately respond to a request from MT Newswires on Thursday seeking comment. The company's ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVO.AU","LU0154236417.USD","BK4532","BK4599","DEO","GLP","LU1093756168.USD","NVO","IE00BKVL7J92.USD","BK4169","LU1093756325.SGD","BK4007","DGE.UK","BK4144","BK7104","IE00BZ1G4Q59.USD","BK4590","BK4585","BK4588"],"gpt_icon":1},{"id":"2502774777","title":"European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2502774777","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502774777?lang=en_us&edition=fundamental","pubTime":"2025-01-09 00:06","pubTimestamp":1736352362,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending lower late Wednesday morning, declining 0.49% to 1,307.19 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies  and Genfit , which rose 5.3% and 4.8% respectively. They were followed by pharmaceutical company Novo Nordisk  and biopharmaceutical company argenx , which were up 2.2% and 1.9% respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis  and semiconductor company Sequans Communications , which fell 7.9% and 5.2% respectively. They were followed by biotech firm Evaxion Biotech  and biopharmaceutical company Grifols , which dropped 2.8% and 2.4% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical company Amarin  and cruise line operator Carnival , which increased 2.7% and 0.6% respectively. They were followed by financial services company HSBC  and mining c","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ARGX","GRFS","BHP","BK4505","TCBP","EVAX","NCNA","NVO.AU","BHP.AU","HSHD.SI","HSBA.UK","LU0154236417.USD","LU0417516738.SGD","LU1481107354.HKD","LU0516423174.USD","LU0540923850.HKD","BK4168","LU0516422440.USD","LU0889565916.HKD","ADAP","BK4207","GNFT","HSBC","LU0516422366.SGD","BK7104","03143","SQNS","BK1610","BK4142","BK4585","DBVT","CUK","TRIB","LU0320765992.SGD","LU0516423091.SGD","BK4139","AMRN","AFG","LU1093756168.USD","BK4599","BK7507","BK4107","BK4521","BK4141","BK4532","LU0164880469.USD","NVO","LU1093756325.SGD","00005","CLLS"],"gpt_icon":1},{"id":"2501278127","title":"Novo Nordisk, Valo Health Expand Collaboration to Include Obesity, Diabetes Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2501278127","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501278127?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:38","pubTimestamp":1736343502,"startTime":"0","endTime":"0","summary":"Novo Nordisk  and Valo Health said Wednesday that they plan to discover and develop new treatments for obesity, type 2 diabetes, and cardiovascular disease.The collaboration is an expansion of an agreement the companies signed in 2023 to develop up to 11 drug programs mainly concerning cardiovascular disease.Under the terms of the amended agreement, Valo will receive an upfront payment, equity investment, and a potential near-term milestone payment of $190 million in total. The company is also eligible to receive milestone payments of approximately $4.6 billion for up to 20 drug programs.Shares of Novo Nordisk were up more than 2% in recent premarket activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a21a55eab3d7674b8aa53f3d6718d66e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BZ1G4Q59.USD","NVO.AU","BK4588","LU1093756168.USD","BK4007","IE00BKVL7J92.USD","BK4599","BK7104","BK4585","LU0154236417.USD","LU1093756325.SGD","BK4532","NVO"],"gpt_icon":1},{"id":"2501558254","title":"European Equities Traded in US as American Depositary Receipts Surge on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2501558254","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501558254?lang=en_us&edition=fundamental","pubTime":"2025-01-07 00:16","pubTimestamp":1736180194,"startTime":"0","endTime":"0","summary":"European equities trading in the US as American depositary receipts were sharply higher late Monday morning, as the S&P Europe Select ADR Index rose 1.6% to 1,315.5.From continental Europe, the gainers were led by biopharmaceutical company Cellectis  and 3D printer company Materialise , which climbed 20% and 6% respectively. They were followed by financial services company Banco Bilbao Vizcaya Argentaria  and semiconductor company Sequans Communications  that increased almost 5% and 3%, respectively.The worst decliners in continental Europe were pharmaceutical company Novo Nordisk  and consumer goods giant Unilever  losing roughly 2% each. They were followed by pharmaceutical company Ascendis Pharma  and Natuzzi , which were down nearly 2% and 1%, respectively.From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics,  and alcoholic beverage company Diageo , gaining 6% and 3%, respectively. They were followed by pharmaceutical company Silence Therape","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ASND","TRIB","BK4082","BK7104","BK4183","NVO.AU","MTLS","BK4023","BK4095","ULVR.UK","DEO","AKTX","BK4162","LU0689626769.HKD","PUK","BK4169","BK4546","BK4588","UN","LU0320765992.SGD","SQNS","BK4592","IE00BKVL7J92.USD","LU1093756168.USD","LU0124676726.USD","WPP","NTZ","SLN","BK4585","IE00BZ1G4Q59.USD","BBVA","UL","BK4599","LU0154236417.USD","WPP.AU","LU0889565916.HKD","AFG","NVO","TCBP","BK4107","BK4139","AUTL","LU1093756325.SGD","BK4141","BK4009","BK4117","BK4007","BK4207","CLLS","DGE.UK"],"gpt_icon":1},{"id":"2500711185","title":"Novo Resources Starts Trading on OTCQB","url":"https://stock-news.laohu8.com/highlight/detail?id=2500711185","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500711185?lang=en_us&edition=fundamental","pubTime":"2025-01-03 07:09","pubTimestamp":1735859359,"startTime":"0","endTime":"0","summary":"Novo Resources (ASX:NVO) started trading on the OTCQB in the US under the ticker symbol \"NSRPF,\" according to a Thursday statement from the company.The mining company previously traded on the OTCQX, per the statement.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVO.AU","BK7104"],"gpt_icon":0},{"id":"2500997291","title":"Novo Resources to Trade on the OTCQB Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2500997291","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500997291?lang=en_us&edition=fundamental","pubTime":"2025-01-03 01:20","pubTimestamp":1735838400,"startTime":"0","endTime":"0","summary":"VANCOUVER, British Columbia, Jan. 02, 2025  -- Novo Resources Corp.    announces that it has transitioned its trading platform from the OTCQX to the OTCQB market in the United States.Effective immediately, Novo Resources will now trade on the OTCQB under the ticker symbol NSRPF. This transition reflects the company's evolving strategic priorities while continuing to provide an opportunity for increased engagement with the U.S. investment community while maintaining access to a highly respected U.S. trading platform.\"We are pleased to make this transition to the OTCQB, which is better suited to our current growth stage and offers a more efficient, cost-effective platform for both our shareholders and potential investors,\" said Mr. Michael Spreadborough, Executive Co-Chairman of Novo Resources. \"Our commitment to advancing gold exploration in Western Australia remains steadfast, and this change will help enhance our market presence in the U.S. and beyond, ultimately supporting our goal o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novo-resources-trade-otcqb-market-172000452.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["NVO.AU","XAO.AU","XKO.AU","XJO.AU","BK7104"],"gpt_icon":1},{"id":"2493279581","title":"Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea","url":"https://stock-news.laohu8.com/highlight/detail?id=2493279581","media":"Investopedia","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493279581?lang=en_us&edition=fundamental","pubTime":"2024-12-24 00:36","pubTimestamp":1734971804,"startTime":"0","endTime":"0","summary":"Eli Lilly's Zepbound has been approved by the Food and Drug Administration  as a treatment for adults with sleep apnea and obesity, the drugmaker said after the bell Friday.Trials of the Lilly drug found that it helped reduce the number of breathing disruptions in an average night of sleep.Over a year, 50% of patients in one trial reported that their sleep apnea symptoms went away.Eli Lilly's  Zepbound has received Food and Drug Administration  approval as a treatment for obstructive sleep apnea for adults with obesity, the drugmaker announced late Friday.The approval comes after several trials earlier this year that showed the tirzepatide-based drug is five times more effective than a placebo at reducingbreathing disruptions caused by obstructive sleep apnea  and in 50% of cases, completely preventing them.\"Zepbound is the first medication that significantly improves moderate-to-severe OSA and aids in long-term weight loss in adults with obesity,\" said Patrik Jonsson, president of Lil","market":"sg","thumbnail":"https://www.investopedia.com/thmb/MsjTDwT0fq0y4TVmTquZgWIYVHA=/4000x2667/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2126120280-94c8334d07474c6883f6bb568b95693f.jpg","type":0,"news_type":0,"thumbnails":["https://www.investopedia.com/thmb/MsjTDwT0fq0y4TVmTquZgWIYVHA=/4000x2667/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2126120280-94c8334d07474c6883f6bb568b95693f.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investopedia.com/lilly-rises-on-fda-approval-of-weight-loss-drug-zepbound-for-sleep-apnea-8765683","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"investopedia_highlight","symbols":["LU0097036916.USD","BK7007","LU2468319806.SGD","RMD","LU2106854487.HKD","LU0471298694.HKD","BK4516","LU1023059063.AUD","IE00B1BXHZ80.USD","IE00BKVL7J92.USD","LU0823416689.USD","LU2324357040.USD","BK4504","GB00BDT5M118.USD","BK4548","BK4532","LU1366192091.USD","RMD.AU","LU1035775433.USD","SG9999013999.USD","NVO","LU2237443622.USD","BK4567","LU2361044949.HKD","SG9999015945.SGD","LU0256863811.USD","LU2602419157.SGD","LU2461242641.AUD","IE00BK4W5L77.USD","SG9999001176.USD","SG9999014880.SGD","LU1974910355.USD","LU2237443465.HKD","LU2491050071.SGD","IE00BJT1NW94.SGD","LLY","IE00BJJMRZ35.SGD","SG9999015952.SGD","LU2237438978.USD","LU1069344957.HKD","LU2237443895.HKD","LU0943347566.SGD","LU0154236417.USD","LU0094547139.USD","SG9999014906.USD","LU2237443978.SGD","LU1291159041.SGD","LU1868836914.USD","BK4534","NVO.AU"],"gpt_icon":1},{"id":"2493381767","title":"European Equities Traded in the US as American Depositary Receipts Start Week Down Slightly in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2493381767","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493381767?lang=en_us&edition=fundamental","pubTime":"2024-12-24 00:04","pubTimestamp":1734969897,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending slightly lower late Monday morning, declining 0.16% to 1,278.01 on the S&P Europe Select ADR Index.From continental Eur","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4117","BK4585","LU0154236417.USD","LU0084288595.USD","LU0648005311.SGD","TCBP","AKTX","MTLS","AUTL","TRVG","BK4588","SLN","BK4134","IE00BKVL7J92.USD","BK4139","BK4546","BK4077","BK4007","NTZ","BK7104","BK4009","BK4107","BK4023","BK4505","BK4532","BK4082","IE00BFMHRM44.USD","AFG","BK4141","NVO.AU","SQNS","BK4599","IE00BZ1G4Q59.USD","MREO","CRTO","BK4142","LU1093756168.USD","VRNA","BK4095","LU1093756325.SGD","CUK","EDAP","NVO","DAVA","EVAX","DAVA.AU"],"gpt_icon":1},{"id":"2493474547","title":"Equity Markets Rise as Traders Evaluate Macro Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2493474547","media":"MT Newswires Live","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493474547?lang=en_us&edition=fundamental","pubTime":"2024-12-21 05:32","pubTimestamp":1734730345,"startTime":"0","endTime":"0","summary":"US benchmark equity indexes closed higher Friday as investors weighed the latest economic data, including a report showing that the Federal Reserve's preferred inflation gauge unexpectedly held steady","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SDS","SDOW","CCL","EQR","VOO","BK4548","SH",".SPX","CCL.AU","OEX","US12M.BOND",".IXIC","BK4581","US2Y.BOND","SPXU","US30Y.BOND","DDM","BK4585","SPY",".DJI","SG9999014021.USD","US6M.BOND","BK4532","DJX","LU1548497426.USD","SSO","DOG","US10Y.BOND","LU0964807845.USD","TSYW.SI","NVO.AU","HUM.AU","SG9999015978.USD","LU0466842654.USD","UPRO","TSLA","US5Y.BOND","SG9999015945.SGD","LU2087621335.USD","LU0266013472.USD","OEF","US7Y.BOND","IVV","DXD","NVO","ESmain","NQmain","US3Y.BOND","HUM"],"gpt_icon":1},{"id":"2493479080","title":"US Equities Markets End Higher Friday as Investors Evaluate Macro Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2493479080","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493479080?lang=en_us&edition=fundamental","pubTime":"2024-12-21 05:02","pubTimestamp":1734728541,"startTime":"0","endTime":"0","summary":"US benchmark equity indexes ended higher Friday as markets parsed the latest economic data, including a report showing that the Federal Reserve's preferred inflation metric unexpectedly held steady la","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["US30Y.BOND","BK4211","MNQmain","LU1093756325.SGD","LU0154236417.USD","DXD","SQQQ","US2Y.BOND","LU0266013472.USD","US5Y.BOND","NVO.AU","QLD","LU0070302665.USD","USAW.SI","TSYW.SI","USJW.SI","US10Y.BOND","NQmain","PSQ","BK4533",".SPX",".DJI","US12M.BOND","BK7104","IE00BKVL7J92.USD","HUM","LU0208291251.USD","DDM","US6M.BOND","DOG","NVO","TQQQ","QID","NVIW.SI","LU0348723411.USD","SG9999014021.USD",".IXIC","ISBC","US7Y.BOND","LU0417517546.SGD","DJX","BK4585","LU0320765489.SGD","IE00BZ1G4Q59.USD","BK4599","US3Y.BOND","SDOW","HUM.AU"],"gpt_icon":1},{"id":"2493260479","title":"Sector Update: Health Care Stocks Rise in Late Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2493260479","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493260479?lang=en_us&edition=fundamental","pubTime":"2024-12-21 04:57","pubTimestamp":1734728256,"startTime":"0","endTime":"0","summary":"Health care stocks advanced late Friday afternoon, with the NYSE Health Care Index up 0.2% and the Health Care Select Sector SPDR Fund (XLV) adding 1.6%.The iShares Biotechnology ETF (IBB) climbed 1.5","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LLY","SNPX","BK4539","GB00BDT5M118.USD","NVO.AU","PFE.AU","LU0114720955.EUR","LU0985481810.HKD","LU1093756168.USD","LU0321505868.SGD","SG9999002224.SGD","LU0823416689.USD","LU0058720904.USD","LU0238689110.USD","IE00B19Z3581.USD","LU0820561909.HKD","LU1066053197.SGD","LU2265009873.SGD","LU0882574139.USD","LU0256863811.USD","LU1988902786.USD","NVO","LU0154236417.USD","BK4007","SG9999003800.SGD","LU1917777945.USD","LU2491050071.SGD","LU2360106947.USD","SG9999011175.SGD","LU1868836914.USD","LU0320765059.SGD","LU1989771016.USD","RXST","SG9999018865.SGD","BK4532","LU2106854487.HKD","IE000M9KFDE8.USD","IE00BK4W5M84.HKD","LU1551013425.SGD","LU1983299246.USD","LU0820561818.USD","LU2237443549.SGD","LU2237443465.HKD","IE00BK4W5L77.USD","IE0009355771.USD","PFE","XLV","IBB","LU0456855351.SGD","BK4588"],"gpt_icon":1}],"pageSize":20,"totalPage":8,"pageCount":4,"totalSize":154,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVO.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVO.AU\",market:\"AU\",,,undefined,":[]}}